Publicaciones en colaboración con investigadores/as de Universitat de València (8)

2022

  1. Evaluation of the Immunomodulatory Effect of the Recombinant 14-3-3 and Major Antigen Proteins of Strongyloides stercoralis against an Infection by S. venezuelensis

    Vaccines, Vol. 10, Núm. 8

2021

  1. Tofacitinib in ulcerative colitis: Real-world evidence from the ENEIDA registry

    Journal of Crohn's and Colitis, Vol. 15, Núm. 1, pp. 35-42

2016

  1. N-(2-methyl-indol-1H-5-yl)-1-naphthalenesulfonamide: A novel reversible antimitotic agent inhibiting cancer cell motility

    Biochemical Pharmacology, Vol. 115, pp. 28-42

2004

  1. LAAE-14, a new anti-inflammatory drug, increases the survival of Candida albicans-inoculated mice

    FEMS Immunology and Medical Microbiology, Vol. 40, Núm. 3, pp. 239-242

2003

  1. LAAE-14, a new in vitro inhibitor of intracellular calcium mobilization, modulates acute and chronic inflammation

    Biochemical Pharmacology, Vol. 65, Núm. 9, pp. 1539-1549

2000

  1. Synthesis and enzyme inhibitory activities of a series of lipidic diamine and aminoalcohol derivatives on cytosolic and secretory phospholipases A2

    Bioorganic and Medicinal Chemistry Letters, Vol. 10, Núm. 3, pp. 285-288

1999

  1. Inhibition of human sPLA2 and 5-lipoxygenase activities by two neo- clerodane diterpenoids

    Life Sciences, Vol. 64, Núm. 19

1993

  1. A comparative study of the population pharmacokinetics of gentamicin and amikacin in newborn patients

    Journal of Clinical Pharmacy and Therapeutics, Vol. 18, Núm. 6, pp. 411-413